Skip to content
Default product image

Anti-Obinutuzumab Polyclonal Antibody

Regular price $405.00 USD
Sale price Regular price

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Applications
ELISA
Clonality
Polyclonal
Form
Liquid
Host
Rabbit
Immunogen
Obinutuzumab
Isotype
IgG
Notes
Antibodysystem can customize this product per customer's request including product size, buffer components, etc. For research use only.
Purification
Purified by antigen affinity column.
Specificity
The product is specific for Obinutuzumab. This antibody serves as an excellent positive control for Obinutuzumab immunogenicity (ADA) assays.
Storage
The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles.
Storage buffer
0.01M PBS, pH 7.4.
Target name
Rabbit polyclonal to Gazyva.
Scientific background
Obinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in Europe, for the treatment of chronic lymphocytic leukemia in combination with chemotherapy in treatment-naive patients, and as a second line treatment for follicular lymphoma. Obinutuzumab is a fully humanized monoclonal antibody that binds to an epitope on CD20 that partially overlaps with the epitope recognized by rituximab. Obinutuzumab binds to CD20 on B cells and causes these cells to be destroyed by engaging the adaptive immune system, directly activating intracellular apoptosis pathways, and activating the complement system.
Technical documents

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab